EquityFlowCompanies › ZuriMED Technologies

ZuriMED Technologies

Healthtech · Zurich, CH

Minimally invasive soft-tissue repair technology (Surgical-Fiberlock).

Funding history

DateRoundAmount
Aug 2023Series A
Zurich-based ZuriMED Technologies raised a CHF14.5M Series A led by Chindex Medical for its soft-tissue repair technology.
$15M

Investors

Chindex MedicalYellowstone Holding

Similar companies in Healthtech

Explore funding flow on EquityFlow →